Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 3.28% · OPTIONAL
· Medicinal Chemicals & Botanical Products
RESEARCH SNAPSHOTCronos Group Inc.'s latest supported as-filed period reports revenue of $53.0M; gross margin moved 1032 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 3.28% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 45.30% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 58.44% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 99.42% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 53.67% · CORE
Level · gp.fundamentals.operating_margin
Raw value 13.97% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -41.2% from the comparable as-filed period.
Gross margin changed +1032 basis points from the comparable as-filed period.
Gross profit changed +96.2% from the comparable as-filed period.
Inventory changed +25.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
CRON · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001710561-26-000001SEC ↗4Aug 7, 2026Period Aug 6, 20260001796640-26-000001SEC ↗4Aug 7, 2026Period Aug 6, 20260001796212-26-000001SEC ↗8-K/AAug 7, 2026Period Jun 18, 20260001656472-26-000053SEC ↗10-QAug 6, 2026Period Jun 30, 20260001656472-26-000051SEC ↗8-KAug 6, 2026Period Aug 6, 20260001656472-26-000050SEC ↗8-KJun 22, 2026Period Jun 18, 20260001656472-26-000039SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 6, 2026Filed Aug 7, 2026 | Garnick Murray RDirector | Grant Or AwardDirect | 48,859.93 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 2.29% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 2.94% · OPTIONAL
Net income changed +180.8% from the comparable as-filed period.
Operating income changed +239.1% from the comparable as-filed period.
Operating margin changed +2988 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001923055-26-000008